The contractor shall test interventional agents in confirmatory and specialized assays in standard format (i.e., cell culture plates with 96 or fewer wells) with the objective of identifying and…
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $165,000
Award facts
- Contract value 100% obligated
- $165,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $165,000 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $165,000.00 cost-plus-fixed-fee contract to Southern Research Institute, doing business as Southern Research, a corporate entity tax-exempt non-profit organization. The contract is for testing interventional agents in confirmatory and specialized assays to identify and characterize at least one agent with activity as part of the In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has a period of performance ending on October 31, 2020 and was awarded on August 1, 2019. Southern Research has provided a range of research and services, including drug discovery and development, to NIH institutes and other federal agencies in the past.
Description
The contractor shall test interventional agents in confirmatory and specialized assays in standard format (i.e., cell culture plates with 96 or fewer wells) with the objective of identifying and characterizing at least one (1) agent with activity to
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $165,000 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award